Aging enhances vascular dysfunction induced by the Alzheimer's peptide β-amyloid

Abstract Aging is a major risk factor for Alzheimer's disease and the evidence suggests a role for cerebrovascular pathology in cognitivedysfunction. The hypothesis in this study is that aging is a significant risk factor in the effect of the Alzheimer peptide β-amyloid on endothelium-dependent function of cerebral and peripheral vessels. The diameter response to acetylcholine, an endothelium-dependent vasodilator, was recorded in pressurized segments of rat posterior cerebral vessels from mature (3 months) and aged (20 months) rats. The threshold concentration of β-amyloid for a significant decrease in the response to acetylcholine was lower in vessels from aged rats (10-9 M) than in vessels from mature rats (10-8 M). The threshold concentration of β-amyloid for a significant decrease in the sensitivity to acetylcholine was lower for ring segments of aorta from aged rats (10-10 M) than for aorta from mature rats (10-8 M). Structural changes of the endothelium were first observed in electron micrographs of aorta from aged rats when the concentration of β-amyloid was 10-8 M, whereas structural changes in aorta from mature rats did not occur until the concentration of β-amyloid was increased to 10-7 M. The results suggest that aging increases the susceptibility of cerebral and peripheral blood vessels to β-amyloid related dysfunction and that functional change precedes structural change.

[1]  P. R. Hof,et al.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders , 1994, Acta Neuropathologica.

[2]  G. Lanzino,et al.  Cerebrovascular disease and cognitive dysfunction , 2002, Neurological research.

[3]  A. Jovanovic,et al.  Ageing is associated with a decrease in the number of sarcolemmal ATP-sensitive K+ channels in a gender-dependent manner , 2002, Mechanisms of Ageing and Development.

[4]  D. Cornfield,et al.  Aβ-peptides enhance vasoconstriction in cerebral circulation , 2001 .

[5]  G. Hellermann,et al.  Physiological levels of β-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production , 2001 .

[6]  LigiaToro,et al.  Decreased Expression of Voltage- and Ca2+-Activated K+ Channels in Coronary Smooth Muscle During Aging , 2001 .

[7]  E. Stefani,et al.  Decreased Expression of Voltage- and Ca 2 1 -Activated K 1 Channels in Coronary Smooth Muscle During Aging , 2001 .

[8]  M. Hasan,et al.  Reduced potassium currents in old rat CA1 hippocampal neurons , 2001, Journal of neuroscience research.

[9]  M. Dujovny,et al.  The neurochemical basis for the applications of the greater omentum in neurosurgery , 2001, Neurological research.

[10]  G. Hellermann,et al.  Potassium channel openers prevent β-amyloid toxicity in bovine vascular endothelial cells , 2000, Neuroscience Letters.

[11]  P. Grammas.  A damaged microcirculation contributes to neuronal cell death in Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[12]  J. C. Torre,et al.  Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesis , 2000, Neurobiology of Aging.

[13]  J. Rhodin,et al.  Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-beta and inflammatory reaction. , 1999, Journal of submicroscopic cytology and pathology.

[14]  J. Price,et al.  The protective effect of K+ channel openers on beta-amyloid induced cerebrovascular endothelial dysfunction. , 1999, Neurological research.

[15]  M. Emmerling,et al.  High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease. , 1999, Biochemical and biophysical research communications.

[16]  D. Borchelt,et al.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.

[17]  D. Heistad,et al.  Regulation of the cerebral circulation: role of endothelium and potassium channels. , 1998, Physiological reviews.

[18]  T. Thomas,et al.  beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain. , 1997, Neurological research.

[19]  D. Sparks.  Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease? , 1997, Annals of the New York Academy of Sciences.

[20]  R. Vos,et al.  Cerebrovascular Hypoperfusion: A Risk Factor for Alzheimer's Disease? , 1997, Annals of the New York Academy of Sciences.

[21]  D. Butterfield.  beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. , 1997, Chemical research in toxicology.

[22]  Sutton Et,et al.  β-Amyloid-Induced Endothelial Necrosis and Inhibition of Nitric Oxide Production☆ , 1997 .

[23]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[24]  N. Relkin,et al.  Decreased senile plaque density in Alzheimer neocortex adjacent to an omental transposition. , 1996, Neurological research.

[25]  C. O'Brien.  Auguste D. and Alzheimer's Disease , 1996, Science.

[26]  L. Fratiglioni.  Epidemiology of Alzheimer's disease and current possibilities for prevention , 1996, Acta neurologica Scandinavica. Supplementum.

[27]  H. Goldsmith.  Omental transposition for Alzheimer 's disease. , 1996, Neurological research.

[28]  P. Hedera,et al.  Differential degeneration of the cerebral microvasculature in Alzheimer's disease. , 1995, Neuroreport.

[29]  B. Zlokovic,et al.  Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.

[30]  F Shishido,et al.  Age-related decline of cerebral oxygen metabolism in normal population detected with positron emission tomography. , 1992, Neurological research.

[31]  B. Pappas,et al.  Aged but not young rats develop metabolic, memory deficits after chronic brain ischaemia. , 1992, Neurological research.

[32]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[34]  D. Heistad,et al.  Effects of aging on responses of cerebral arterioles. , 1990, The American journal of physiology.